Deal Announcements

Arsenal Vascular Adds $3 Million Venture Financing

Wednesday, November 09, 2011 5:31:00 AM PDT | VentureDeal Staff

   Watertown, Massachusetts  --  Biotechnology company Arsenal Vascular (formerly called Arsenal Medical) has garnered $3 million in new venture capital funding, according to an SEC regulatory filing.

Arsenal is developing therapeutic products "based on its proprietary BioActive Composites platform."

Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.

Arsenal is backed by a syndicate of top-tier venture capital firms including Polaris Venture Partners, North Bridge Venture Partners, Essex Woodlands Health Ventures and Intersouth Partners.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1